Medication info
Double Star Tablet 40/10 mg

Double Star Tablet 40/10 mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
TDS Pharm Co., Ltd.
Appearance
Biconvex oval double tablet in white and light blue color
Packaging
30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900625 · Approved 2019.01.24 · Insurance code 679801760

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
TDS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of either telmisartan or amlodipine. It helps reduce the risk of cardiovascular complications and improve the patient’s health status.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Administration of this medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued immediately. Patients with allergies to any components of this medication or similar drugs, those who are pregnant or breastfeeding, and patients with severely impaired liver function should not take this drug. Patients with serious heart or blood pressure problems should also avoid this medication. Patients with certain diseases, such as primary aldosteronism, heart valve disease, or liver disease, should use this drug with caution. Patients with gastrointestinal diseases, kidney diseases, or the elderly should also be careful when taking this medication. Since this drug lowers blood pressure, there is a risk of hypotension, and immediate action should be taken if symptoms appear. Furthermore, there may be a risk of elevated blood potassium levels, so regular blood tests may be necessary. Side effects such as dizziness, drowsiness, and visual disturbances may occur while taking this medication, so caution should be exercised when driving or operating machinery. There may be interactions with other medications, so it is essential to consult with a doctor or pharmacist. In case of overdose, hypotension and heart problems may occur, and immediate medical assistance should be sought. This medication is not recommended for children, and elderly patients should adjust the dosage accordingly. When storing, keep out of reach of children and ensure it is not exposed to moisture.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver disorders
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • elevated blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container to protect it from light and air, and it is advisable to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature). Proper storage will help ensure the safety of the medication's effectiveness.

Appearance and packaging

Appearance

Biconvex oval double tablet in white and light blue color

Package unit

30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.